Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313339849> ?p ?o ?g. }
- W4313339849 abstract "Dysregulated activation of the inflammasome is involved in various human diseases including acute cerebral ischemia, multiple sclerosis and sepsis. Though many inflammasome inhibitors targeting NOD-like receptor protein 3 (NLRP3) have been designed and developed, none of the inhibitors are clinically available. Growing evidence suggests that targeting apoptosis-associated speck-like protein containing a CARD (ASC), the oligomerization of which is the key event for the assembly of inflammasome, may be another promising therapeutic strategy. Lonidamine (LND), a small-molecule inhibitor of glycolysis used as an antineoplastic drug, has been evidenced to have anti-inflammation effects. However, its anti-inflammatory mechanism is still largely unknown.Middle cerebral artery occlusion (MCAO), experimental autoimmune encephalomyelitis (EAE) and LPS-induced sepsis mice models were constructed to investigate the therapeutic and anti-inflammasome effects of LND. The inhibition of inflammasome activation and ASC oligomerization by LND was evaluated using western blot (WB), immunofluorescence (IF), quantitative polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assay (ELISA) in murine bone marrow-derived macrophages (BMDMs). Direct binding of LND with ASC was assessed using molecular mock docking, surface plasmon resonance (SPR), and drug affinity responsive target stability (DARTS).Here, we find that LND strongly attenuates the inflammatory injury in experimental models of inflammasome-associated diseases including autoimmune disease-multiple sclerosis (MS), ischemic stroke and sepsis. Moreover, LND blocks diverse types of inflammasome activation independent of its known targets including hexokinase 2 (HK2). We further reveal that LND directly binds to the inflammasome ligand ASC and inhibits its oligomerization.Taken together, our results identify LND as a broad-spectrum inflammasome inhibitor by directly targeting ASC, providing a novel candidate drug for the treatment of inflammasome-driven diseases in clinic." @default.
- W4313339849 created "2023-01-06" @default.
- W4313339849 creator A5005522080 @default.
- W4313339849 creator A5013884354 @default.
- W4313339849 creator A5025108012 @default.
- W4313339849 creator A5029843246 @default.
- W4313339849 creator A5034868438 @default.
- W4313339849 creator A5047254983 @default.
- W4313339849 creator A5051310827 @default.
- W4313339849 creator A5055284616 @default.
- W4313339849 creator A5059058103 @default.
- W4313339849 creator A5063253432 @default.
- W4313339849 creator A5066632653 @default.
- W4313339849 creator A5067367860 @default.
- W4313339849 creator A5074972789 @default.
- W4313339849 creator A5077982252 @default.
- W4313339849 creator A5080366654 @default.
- W4313339849 creator A5082960075 @default.
- W4313339849 creator A5086926657 @default.
- W4313339849 creator A5087514826 @default.
- W4313339849 creator A5091210010 @default.
- W4313339849 date "2022-12-28" @default.
- W4313339849 modified "2023-10-16" @default.
- W4313339849 title "Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases" @default.
- W4313339849 cites W1655763950 @default.
- W4313339849 cites W1680053970 @default.
- W4313339849 cites W1698594938 @default.
- W4313339849 cites W1743744546 @default.
- W4313339849 cites W1916611915 @default.
- W4313339849 cites W1966183236 @default.
- W4313339849 cites W1971915082 @default.
- W4313339849 cites W1972483153 @default.
- W4313339849 cites W1987329700 @default.
- W4313339849 cites W1993976394 @default.
- W4313339849 cites W1994505366 @default.
- W4313339849 cites W1995005155 @default.
- W4313339849 cites W2009800174 @default.
- W4313339849 cites W2027347547 @default.
- W4313339849 cites W2032370476 @default.
- W4313339849 cites W2049683923 @default.
- W4313339849 cites W2054571187 @default.
- W4313339849 cites W2067043938 @default.
- W4313339849 cites W2079882002 @default.
- W4313339849 cites W2081262717 @default.
- W4313339849 cites W2086546470 @default.
- W4313339849 cites W2090859543 @default.
- W4313339849 cites W2096317294 @default.
- W4313339849 cites W2120815988 @default.
- W4313339849 cites W2134007048 @default.
- W4313339849 cites W2137368645 @default.
- W4313339849 cites W2140637559 @default.
- W4313339849 cites W2143119237 @default.
- W4313339849 cites W2144275312 @default.
- W4313339849 cites W2161290719 @default.
- W4313339849 cites W2232178678 @default.
- W4313339849 cites W2318238011 @default.
- W4313339849 cites W2351673993 @default.
- W4313339849 cites W2398990619 @default.
- W4313339849 cites W2431987552 @default.
- W4313339849 cites W2460289322 @default.
- W4313339849 cites W2464242197 @default.
- W4313339849 cites W2476852255 @default.
- W4313339849 cites W2517793347 @default.
- W4313339849 cites W2527001605 @default.
- W4313339849 cites W2605685784 @default.
- W4313339849 cites W2724425486 @default.
- W4313339849 cites W2774676125 @default.
- W4313339849 cites W2775627975 @default.
- W4313339849 cites W2777928756 @default.
- W4313339849 cites W2778820157 @default.
- W4313339849 cites W2790012847 @default.
- W4313339849 cites W2790572647 @default.
- W4313339849 cites W2791444686 @default.
- W4313339849 cites W2791711864 @default.
- W4313339849 cites W2793830108 @default.
- W4313339849 cites W2810072585 @default.
- W4313339849 cites W2884445384 @default.
- W4313339849 cites W2889446669 @default.
- W4313339849 cites W2895754752 @default.
- W4313339849 cites W2915252464 @default.
- W4313339849 cites W2920248606 @default.
- W4313339849 cites W2944766235 @default.
- W4313339849 cites W2946298400 @default.
- W4313339849 cites W2959497269 @default.
- W4313339849 cites W2964003958 @default.
- W4313339849 cites W2988152617 @default.
- W4313339849 cites W2990249901 @default.
- W4313339849 cites W2992534356 @default.
- W4313339849 cites W3006659767 @default.
- W4313339849 cites W3014630476 @default.
- W4313339849 cites W3015393370 @default.
- W4313339849 cites W3021185062 @default.
- W4313339849 cites W3088917286 @default.
- W4313339849 cites W3119880113 @default.
- W4313339849 cites W4200398559 @default.
- W4313339849 cites W4211217520 @default.
- W4313339849 cites W90330895 @default.
- W4313339849 doi "https://doi.org/10.1186/s12974-022-02682-w" @default.
- W4313339849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36577999" @default.
- W4313339849 hasPublicationYear "2022" @default.